Application of engineered CRISPR/Cas12a variants with altered protospacer adjacent motif specificities for the detection of isoniazid resistance mutations in Mycobacterium tuberculosis
Microbiology Spectrum · 2025
DOI: 10.1128/spectrum.00165-25 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbiology Spectrum, 2025. Verfasst von Peng Liu und 8 weiteren Autor:innen. Beteiligte Einrichtung: National Clinical Research Center for Infectious Diseases, Guangdong Provincial Clinical Research Center for Tuberculosis, Shenzhen Third People's Ho…. Hauptthemen laut MEDLINE: Isoniazid, Mycobacterium tuberculosis, CRISPR-Cas Systems, Antitubercular Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Drug-resistant tuberculosis (TB) is a major global public health concern. Although isoniazid is currently considered one of the most effective first-line drugs for TB treatment, its efficacy is limited by the emergence of resistance. Therefore, it is imperative to develop new methods for detecting drug-resistant TB. In this study, we developed a nucleic acid detection system based on the clustered regularly interspaced short palindromic repeat (CRISPR) Cas12a_RR protein. The system combines recombinase polymerase amplification with an engineered CRISPR/Cas12a_RR protein to enable rapid and specific detection of the katG G944C mutation in isoniazid-resistant Mycobacterium tuberculosis ( Mtb ). It could detect the target DNA at concentrations as low as 1% in a mixed sample. Compared with TaqMan quantitative polymerase chain reaction and DNA sequencing, the CRISPR/Cas12a_RR system demonstrated superior detection performance in terms of sensitivity, specificity, and cost-effectiveness. Furthermore, it effectively differentiated between drug-resistant Mtb strains from wild-type Mtb strains in clinically isolated samples, with the entire detection process completed in 60 min. In conclusion, the CRISPR/Cas12a_RR detection system offers a novel, rapid, simple, sensitive, and specific approach for identifying isoniazid-resistant Mtb , with significant potential for clinical application, particularly in resource-limited settings. IMPORTANCE This study presents a novel method for detecting isoniazid-resistant Mycobacterium tuberculosis ( Mtb ) using clustered regularly interspaced short palindromic repeat (CRISPR)/Cas12a mutants, offering rapid detection, cost-effectiveness, and high specificity, and thereby providing a promising new avenue for detecting isoniazid-resistant Mtb .
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Clinical Research Center for Infectious Diseases, Guangdong Provincial Clinical Research Center for Tuberculosis, Shenzhen Third People's Hospital, Southern University of Science and Technology, Shenzhen, China.
- Wuhan Pulmonary Hospital, Wuhan Tuberculosis Prevention and Control Institute, The Hubei Branch of the National Clinical Research Center for Infectious Disease, Wuhan, China.
- Intensive Care Unit, Liyuan Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
- Clinical Laboratory Experiment Center, Hangzhou Red Cross Hospital, Zhejiang, China.
ORCID-Profile: Guohui Xiao, Guoliang Zhang
Zitieren
APA
Liu, P., Zhang, J., Gong, Y., Liu, W., Xiao, G., Liang, J., Wang, X., Bi, J., & Zhang, G. (2025). Application of engineered CRISPR/Cas12a variants with altered protospacer adjacent motif specificities for the detection of isoniazid resistance mutations in Mycobacterium tuberculosis. Microbiology Spectrum. https://doi.org/10.1128/spectrum.00165-25
Vancouver
Liu P, Zhang J, Gong Y, Liu W, Xiao G, Liang J, et al. Application of engineered CRISPR/Cas12a variants with altered protospacer adjacent motif specificities for the detection of isoniazid resistance mutations in Mycobacterium tuberculosis. Microbiology Spectrum. 2025. doi:10.1128/spectrum.00165-25
BibTeX
@article{Liu2025,
author = {Liu, Peng and Zhang, Jinping and Gong, Yaqi and Liu, Wenqi and Xiao, Guohui and Liang, Juan and Wang, Xuan and Bi, Jing and Zhang, Guoliang},
title = {Application of engineered CRISPR/Cas12a variants with altered protospacer adjacent motif specificities for the detection of isoniazid resistance mutations in Mycobacterium tuberculosis},
journal = {Microbiology Spectrum},
year = {2025},
doi = {10.1128/spectrum.00165-25}
}
EUVIMED